Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2003 Nov;88(11):974–975. doi: 10.1136/adc.88.11.974

Vitamin K supplementation in cystic fibrosis

J H L van Hoorn 1, J Hendriks 1, C Vermeer 1, F Ph 1
PMCID: PMC1719368  PMID: 14612359

Full Text

The Full Text of this article is available as a PDF (100.5 KB).

Figure 1 .

Figure 1

Boxplot showing total osteocalcin (t-OC in black), undercarboxylated osteocalcin (u-OC in grey), and carboxylated osteocalcin (c-OC in white) for vitamin K supplementation in CF patients, compared to healthy controls. Vitamin K supplementation is shown in three different groups: CFno = no supplementation; CFlow = <0.25 mg/day; and CFhigh = ⩾1 mg/day. Significant p values are shown.

Figure 2 .

Figure 2

Boxplot showing PIVKA-II concentrations in CF patients with three different doses of vitamin K supplementation, compared to healthy controls. Significant p values are shown.


Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES